PL2952190T3 - Trwały roztwór wodny - Google Patents

Trwały roztwór wodny

Info

Publication number
PL2952190T3
PL2952190T3 PL14745605T PL14745605T PL2952190T3 PL 2952190 T3 PL2952190 T3 PL 2952190T3 PL 14745605 T PL14745605 T PL 14745605T PL 14745605 T PL14745605 T PL 14745605T PL 2952190 T3 PL2952190 T3 PL 2952190T3
Authority
PL
Poland
Prior art keywords
aqueous solution
stable aqueous
stable
solution
aqueous
Prior art date
Application number
PL14745605T
Other languages
English (en)
Inventor
Yuko Shikamura
Yuka Higashimura
Original Assignee
Senju Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co., Ltd. filed Critical Senju Pharmaceutical Co., Ltd.
Publication of PL2952190T3 publication Critical patent/PL2952190T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL14745605T 2013-01-31 2014-01-30 Trwały roztwór wodny PL2952190T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2013017877 2013-01-31
JP2013171433 2013-08-21
EP14745605.7A EP2952190B1 (en) 2013-01-31 2014-01-30 Stable aqueous solution
PCT/JP2014/052040 WO2014119642A1 (ja) 2013-01-31 2014-01-30 安定な水性液剤

Publications (1)

Publication Number Publication Date
PL2952190T3 true PL2952190T3 (pl) 2018-02-28

Family

ID=51262353

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14745605T PL2952190T3 (pl) 2013-01-31 2014-01-30 Trwały roztwór wodny

Country Status (12)

Country Link
US (1) US20150366966A1 (pl)
EP (1) EP2952190B1 (pl)
JP (1) JP5753957B2 (pl)
KR (1) KR20150110775A (pl)
CN (2) CN105007918B (pl)
BR (1) BR112015017708A2 (pl)
CA (1) CA2899292A1 (pl)
ES (1) ES2650748T3 (pl)
MX (1) MX365408B (pl)
PL (1) PL2952190T3 (pl)
RU (1) RU2665639C2 (pl)
WO (1) WO2014119642A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9968679B2 (en) 2013-01-31 2018-05-15 Senju Pharmaceutical Co., Ltd. Clear aqueous solution
EP3970694A1 (en) 2017-05-11 2022-03-23 Vyluma Inc. Atropine pharmaceutical compositions
CN117571642A (zh) * 2024-01-12 2024-02-20 天津世纪康泰生物医学工程有限公司 一种泰洛沙泊分光光度检测方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
JP4171529B2 (ja) 1995-06-26 2008-10-22 大正製薬株式会社 点眼剤の充填容器
JPH11228404A (ja) * 1997-12-11 1999-08-24 Senju Pharmaceut Co Ltd 安定な水性点眼剤
WO2002067977A1 (fr) * 2001-02-26 2002-09-06 Kowa Company, Ltd. Gouttes ophtalmiques
MXPA04003398A (es) 2001-10-12 2004-11-22 Nippon Chemiphar Co Activador para el receptor o activado con el proliferador de peroxisoma.
WO2004006826A1 (ja) 2002-07-16 2004-01-22 Senju Pharmaceutical Co., Ltd. 薬液容器及びその製造方法
WO2004064828A1 (ja) * 2003-01-21 2004-08-05 Senju Pharmaceutical Co., Ltd. 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性液剤
JP2005247800A (ja) * 2004-03-08 2005-09-15 Zeria Pharmaceut Co Ltd 点眼剤
BRPI0811612A2 (pt) * 2007-05-21 2014-11-11 Senju Pharma Co Composições farmacêuticas que contêm agonista ppardelta
JP5668476B2 (ja) * 2007-10-08 2015-02-12 オーリニア・ファーマシューティカルズ・インコーポレイテッドAurinia Pharmaceuticals Inc. カルシニューリン阻害剤またはmTOR阻害剤を含む眼科用組成物
US9968679B2 (en) * 2013-01-31 2018-05-15 Senju Pharmaceutical Co., Ltd. Clear aqueous solution
RU2635185C2 (ru) * 2013-12-17 2017-11-09 Иван Дмитриевич Захаров Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости

Also Published As

Publication number Publication date
RU2665639C2 (ru) 2018-09-03
MX2015009894A (es) 2015-09-24
MX365408B (es) 2019-05-31
JP5753957B2 (ja) 2015-07-22
EP2952190A1 (en) 2015-12-09
ES2650748T3 (es) 2018-01-22
WO2014119642A1 (ja) 2014-08-07
JPWO2014119642A1 (ja) 2017-01-26
BR112015017708A2 (pt) 2017-07-11
CN108606951A (zh) 2018-10-02
CN105007918B (zh) 2018-06-15
US20150366966A1 (en) 2015-12-24
CA2899292A1 (en) 2014-08-07
EP2952190B1 (en) 2017-09-06
RU2015136804A (ru) 2017-03-06
KR20150110775A (ko) 2015-10-02
CN105007918A (zh) 2015-10-28
EP2952190A4 (en) 2016-08-24

Similar Documents

Publication Publication Date Title
IL240863A0 (en) Amatoxin derivatives
SG11201506100XA (en) Pyridazinone-amides derivatives
SG11201601493UA (en) Atomizer
IL245920A0 (en) Ionic aqueous preparations
SMT201900363T1 (it) Sali di aramchol
ZA201601333B (en) Oxoquinazolinyl-butanamide derivatives
SG10201801458VA (en) Ophthalmic solution
GB201321922D0 (en) Constructions
SG11201605189YA (en) Imidazopyrazinone derivatives
EP2952190A4 (en) STABLE AYE SOLUTION
EP2952189A4 (en) CLEAN AQUEOUS SOLUTION
GB201311130D0 (en) Greensleeves I
AU5187P (en) WES06 Westringia fruticosa
IL245452A0 (en) Salts of Armachol
GB201312171D0 (en) Total patent solution
GB201309252D0 (en) Total patent solution
ZA201406179B (en) Cleansing solution
GB201304401D0 (en) Simplistic Esycone
GB201308346D0 (en) Double ended match
GB201304478D0 (en) Swings
GB201319794D0 (en) Drawcode